Abstract
Immunohistochemistry (IHC) is an integral laboratory staining technique, which is used for the detection of immune cells in mouse/human tissues or tumors. Oncolytic herpes simplex virus (oHSV) treatment or virotherapy of solid tumors results in antitumor immune responses and infiltration of a variety of immune cells into the tumor. Here, we describe a step-by-step chromogen/substrate-based single- and dual-color IHC protocol to stain immune cells in formalin-fixed, paraffin-embedded mouse glioblastoma (GBM) brain tumor sections after oHSV virotherapy. Tumor sections are deparaffinized with xylene, then gradually rehydrated using ethanol, followed by heat-mediated antigen retrieval using appropriate buffers. Tumor sections are incubated with primary antibodies, which detect a specific immune cell antigen, then incubated with peroxidase- or phosphatase-labeled secondary antibodies, followed by incubation with a color-producing substrate and color visualization (of immune cells) by light microscopy. The protocol described herein is also applicable to detect immune cells in other mouse and human tumors or organs after other forms of immunotherapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Saha D, Ahmed SS, Rabkin SD (2015) Exploring the antitumor effect of virus in malignant glioma. Drugs Future 40(11):739–749. https://doi.org/10.1358/dof.2015.040.11.2383070
Saha D, Wakimoto H, Rabkin SD (2016) Oncolytic herpes simplex virus interactions with the host immune system. Curr Opin Virol 21:26–34. https://doi.org/10.1016/j.coviro.2016.07.007
Bommareddy PK, Peters C, Saha D, Rabkin SD, Kaufman HL (2018) Oncolytic herpes simplex viruses as a paradigm for the treatment of cancer. Annu Rev Cancer Biol 2(1):155–173. https://doi.org/10.1146/annurev-cancerbio-030617-050254
Saha D, Martuza RL, Rabkin SD (2017) Macrophage polarization contributes to Glioblastoma eradication by combination immunovirotherapy and immune checkpoint blockade. Cancer Cell 32(2):253–267 e255. https://doi.org/10.1016/j.ccell.2017.07.006
Saha D, Wakimoto H, Peters CW, Antoszczyk SJ, Rabkin SD, Martuza RL (2018) Combinatorial effects of VEGFR kinase inhibitor axitinib and oncolytic virotherapy in mouse and human glioblastoma stem-like cell models. Clin Cancer Res 24(14):3409–3422. https://doi.org/10.1158/1078-0432.CCR-17-1717
Hofman FM, Taylor CR (2013) Immunohistochemistry. Curr Protoc Immunol 103:Unit 21 24. https://doi.org/10.1002/0471142735.im2104s103
Goldstein M, Watkins S (2008) Immunohistochemistry. Curr Protoc Mol Biol:Chapter 14: Unit 14 16. https://doi.org/10.1002/0471142727.mb1406s81
Ramos-Vara JA (2005) Technical aspects of immunohistochemistry. Vet Pathol 42(4):405–426. https://doi.org/10.1354/vp.42-4-405
Ward JM, Rehg JE (2014) Rodent immunohistochemistry: pitfalls and troubleshooting. Vet Pathol 51(1):88–101. https://doi.org/10.1177/0300985813503571
Donaldson JG (2015) Immunofluorescence staining. Curr Protoc Cell Biol 69(4.3):1–7. https://doi.org/10.1002/0471143030.cb0403s69
Acknowledgments
This work was supported in part by grants from NIH (R01CA160762) and the Thomas A. Pappas Chair in Neuroscience to SDR.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Saha, D., Rabkin, S.D. (2020). Immunohistochemistry for Tumor-Infiltrating Immune Cells After Oncolytic Virotherapy. In: Engeland, C. (eds) Oncolytic Viruses. Methods in Molecular Biology, vol 2058. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9794-7_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9794-7_11
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9793-0
Online ISBN: 978-1-4939-9794-7
eBook Packages: Springer Protocols